Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Neurologic Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Neurologic Other
    Small Bedside Monitors Detect Seizures in At-Risk Newborns - (DGNews)
    Early Gastric Feeding Following Traumatic Brain Injury Improves Likelihood for Survival - (DGNews)
    Silent Cerebral Infarction Reported in 10% of Healthy People - (DGNews)
    Subtle Nervous System Abnormalities Predict Risk of Death in Elderly - (DGNews)
    Incident Dementia Reduced by Antihypertensive Therapy in Elderly Hypertensive Patients: Presented at ESH - (DGDispatch)

    News archive

     Recent webcasts/CME - Neurologic Other
    • Dementia in Hispanic Americans: The Reasons Behind the Risk
    • Modifiable Risk Factors Underlie Higher Dementia Rates in African Americans
    • Battling Chronic Fatigue Syndrome
      Brain Cooling for the Treatment of Perinatal Hypoxic-Ischemic Encephalopathy
      Delirium Update

      Webcasts/CME archive

       Recent cases - Neurologic Other
        Solitary Skull Metastasis as Initial Manifestation of Hepatocellular Carcinoma
        Perthes Syndrome Associated with Intramedullary Spinal Cord Hemorrhage in a 4-Year-Old Child: A Case Report
        Snake Bite Mimicking Brain Death
        Henoch-Schonlein Purpura with Intracerebral Haemorrhage in an Adult Patient: A Case Report
        Compression of the Median Nerve in the Proximal Forearm by a Giant Lipoma: A Case Report

        Cases archive
          




        my personal edition > neurologic other > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        FDA Grants Orphan Drug Status to Creatine for Amyotrophic Lateral Sclerosis

        SAN FRANCISCO, CA -- March 26, 2002 -- The Avicena Group, Inc. announced that it has received Orphan Drug Designation from the United States Food and Drug Administration (FDA) for creatine to treat patients with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's Disease.

        The company plans to submit an investigative new drug application this year.

        Creatine is a critical element in cellular energy production and modulation. It is the substrate of the creatine kinase system, which helps prolong cellular life and protect against cell injury and death.

        Avicena is supporting three clinical studies on the effects of creatine among ALS patients. A pilot study was conducted at Cornell Medical Center in 1999. Ongoing Phase II/III studies, started in 1999, are being conducted at multiple centers coordinated by the Carolinas Neuromuscular ALS/MDA Center in Charlotte North Carolina and the North East ALS Consortium, consisting of over 300 patients at 29 sites. Preliminary data from three centers in the Carolinas Neuromuscular/ALS study are very encouraging.

        Dr. Jeffrey Rosenfeld, director of the Carolinas Neuromuscular ALS/MDA Center and lead investigator of the Carolinas Neuromuscular ALS study, commented, "We have seen, and continue to see, encouraging results among ALS patients, as measured by muscle strength and a decreased rate of deterioration. Additionally, creatine has a long history of safe use, and is well tolerated by patients in the study."

        These clinical studies build on Avicena's extensive pre-clinical studies, 14 of which have been published, which demonstrate that creatine, in transgenic mouse models, has a neuroprotective effect in ALS, Huntington's disease, and Parkinson's disease.

        ALS is a progressive and fatal disease that attacks motor neurons, the components of the nervous system that connect the brain with the skeletal muscles. More than 5000 people in the U.S. are diagnosed with ALS each year, with about 30,000 having the disease at any given time. Worldwide, ALS occurs in one out of every 100,000 people across racial, socioeconomic and ethnic boundaries.

        SOURCE: The Avicena Group




        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send